DD246318A5 - Neue genetische Sequenzen, die durch die codierten Interferon-Peptide vom Typ I und diese sie produzierende Organismen - Google Patents

Neue genetische Sequenzen, die durch die codierten Interferon-Peptide vom Typ I und diese sie produzierende Organismen Download PDF

Info

Publication number
DD246318A5
DD246318A5 DD27937585A DD27937585A DD246318A5 DD 246318 A5 DD246318 A5 DD 246318A5 DD 27937585 A DD27937585 A DD 27937585A DD 27937585 A DD27937585 A DD 27937585A DD 246318 A5 DD246318 A5 DD 246318A5
Authority
DD
German Democratic Republic
Prior art keywords
leu
ser
ctg
arg
gin
Prior art date
Application number
DD27937585A
Other languages
German (de)
English (en)
Inventor
Rudolf Hauptmann
Peter Meindl
Eva Dworkin-Rastl
Guenther Adolf
Peter Swetly
Christian Pieler
Norbert Hauel
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3428370A external-priority patent/DE3428370A1/de
Priority claimed from DE19853505060 external-priority patent/DE3505060A1/de
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of DD246318A5 publication Critical patent/DD246318A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DD27937585A 1984-08-01 1985-07-29 Neue genetische Sequenzen, die durch die codierten Interferon-Peptide vom Typ I und diese sie produzierende Organismen DD246318A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3428370A DE3428370A1 (de) 1984-08-01 1984-08-01 Interferon, genetische sequenzen, die hierfuer codieren, und diese produzierende organismen
DE19853505060 DE3505060A1 (de) 1985-02-14 1985-02-14 Neue interferone vom typ i, genetische sequenzen, die hierfuer codieren, und diese produzierende organismen

Publications (1)

Publication Number Publication Date
DD246318A5 true DD246318A5 (de) 1987-06-03

Family

ID=25823496

Family Applications (1)

Application Number Title Priority Date Filing Date
DD27937585A DD246318A5 (de) 1984-08-01 1985-07-29 Neue genetische Sequenzen, die durch die codierten Interferon-Peptide vom Typ I und diese sie produzierende Organismen

Country Status (21)

Country Link
EP (1) EP0170204B1 (el)
JP (2) JP2566909B2 (el)
KR (1) KR0136799B1 (el)
AT (1) ATE67786T1 (el)
AU (1) AU600653B2 (el)
BG (1) BG60445B2 (el)
CA (1) CA1340184C (el)
DD (1) DD246318A5 (el)
DE (1) DE3584198D1 (el)
DK (1) DK175194B1 (el)
ES (2) ES8609475A1 (el)
FI (1) FI90667C (el)
GR (1) GR851866B (el)
HK (1) HK187896A (el)
HU (1) HU205779B (el)
IE (1) IE58942B1 (el)
IL (1) IL75963A (el)
MX (1) MX9203645A (el)
NO (1) NO177863C (el)
NZ (1) NZ212937A (el)
PT (1) PT80901B (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231176A (en) * 1984-08-27 1993-07-27 Genentech, Inc. Distinct family DNA encoding of human leukocyte interferons
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
EP0490233A1 (de) * 1986-03-10 1992-06-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Monoclonale Antikörper gegen BgIII-Hybridinterferone, deren Verwendung und Verfahren zu ihrer Herstellung
US4863727A (en) * 1986-04-09 1989-09-05 Cetus Corporation Combination therapy using interleukin-2 and tumor necrosis factor
DE3633323A1 (de) * 1986-10-01 1988-04-07 Boehringer Ingelheim Int Neue monoklonale antikoerper gegen ifn-omega, verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega
DE3635867A1 (de) * 1986-10-22 1988-05-11 Boehringer Ingelheim Int Neue hefeexpressionsvektoren fuer ifn-omega, verfahren zu ihrer herstellung und deren verwendung
EP1987845B1 (en) 1997-11-20 2012-03-21 Vical Incorporated Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor.
WO2000040273A2 (en) * 1999-01-08 2000-07-13 Vical Incorporated Treatment of viral diseases using an interferon omega expressing polynucleotide
CA2477794C (en) 2002-03-07 2013-08-20 Eidgenoessische Technische Hochschule Zuerich System and method for the production of recombinant glycosylated proteins in a prokaryotic host
KR20100119905A (ko) * 2002-03-07 2010-11-11 아이드게노쉬쉐 테흐니쉐 호흐슐레 쥬리히 원핵 숙주에서의 재조합 글리코실화 단백질 생산 방법 및 생산계
PL1615945T3 (pl) 2003-04-09 2012-03-30 Ratiopharm Gmbh Sposoby glikopegylacji i białka/peptydy wytwarzane tymi sposobami
WO2004096852A1 (fr) * 2003-04-25 2004-11-11 The Institute Of Microbiology And Epidemiology, Academy Of Military Medical Sciemces, Pla Interferon$g(v) humain recombinant, son procede d'expression et ses utilisations
EP2853600B1 (en) 2005-05-11 2018-09-19 ETH Zürich Recombinant N-glycosylated proteins from procaryotic cells
EP3427749A1 (en) 2008-02-20 2019-01-16 GlaxoSmithKline Biologicals SA Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells
WO2011062615A1 (en) 2009-11-19 2011-05-26 Glycovaxyn Ag Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells
EP2566507B1 (en) 2010-05-06 2017-11-22 GlaxoSmithKline Biologicals SA Capsular gram-positive bacteria bioconjugate vaccines
WO2013024158A1 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of protein kinase inhibitors and interferons or of protein kinase inhibitors and direct acting antivirals for the treatment and the prevention of hcv infection
WO2013024156A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection
WO2014033266A1 (en) 2012-08-31 2014-03-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Anti-sr-bi antibodies for the inhibition of hepatitis c virus infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1946283A (en) * 1982-08-18 1984-03-07 Cetus Corporation Interferon-alpha 6l
CA1217440A (en) * 1982-08-18 1987-02-03 Michael A. Innis INTERFERON .alpha. 6L
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
DE3574145D1 (en) * 1984-08-27 1989-12-14 Genentech Inc Novel, distinct family of human leukocyte interferons, compositions containing them, methods for their production, and dna and transfected hosts therefor

Also Published As

Publication number Publication date
HU205779B (en) 1992-06-29
EP0170204A2 (de) 1986-02-05
DE3584198D1 (de) 1991-10-31
PT80901A (de) 1985-09-01
EP0170204A3 (en) 1988-02-17
KR0136799B1 (ko) 1998-04-25
IE851906L (en) 1986-02-01
ES8708013A1 (es) 1987-09-01
FI90667B (fi) 1993-11-30
ATE67786T1 (de) 1991-10-15
HUT39477A (en) 1986-09-29
EP0170204B1 (de) 1991-09-25
DK346385D0 (da) 1985-07-30
NZ212937A (en) 1991-08-27
IL75963A0 (en) 1985-12-31
IL75963A (en) 1992-05-25
FI852956A0 (fi) 1985-07-31
DK346385A (da) 1986-02-02
CA1340184C (en) 1998-12-15
ES8609475A1 (es) 1986-08-01
AU600653B2 (en) 1990-08-23
IE58942B1 (en) 1993-12-01
NO853012L (no) 1986-02-03
GR851866B (el) 1985-12-02
JPS61181381A (ja) 1986-08-14
FI852956L (fi) 1986-02-02
ES545725A0 (es) 1986-08-01
JP2566909B2 (ja) 1996-12-25
NO177863C (no) 1995-12-06
JP2567195B2 (ja) 1996-12-25
ES552431A0 (es) 1987-09-01
KR870001310A (ko) 1987-03-13
JPH06181771A (ja) 1994-07-05
PT80901B (pt) 1989-01-17
NO177863B (no) 1995-08-28
BG60445B2 (bg) 1995-03-31
MX9203645A (es) 1992-09-01
HK187896A (en) 1996-10-18
AU4554985A (en) 1986-02-06
DK175194B1 (da) 2004-07-05
FI90667C (fi) 1994-03-10

Similar Documents

Publication Publication Date Title
DE3238554C2 (el)
DE3544520C2 (de) Hunde-Interferone
EP0236920B1 (de) Hybridinterferone, deren Verwendung als Arzneimittel und als Zwischenprodukte zur Herstellung von Antikörpern und deren Verwendung sowie Verfahren zu ihrer Herstellung
EP0170204B1 (de) Neue genetische Sequenzen, die durch sie codierten Interferon-Peptide vom Typ I und diese sie produzierende Organismen
EP0271824B1 (de) Pferde-Gamma-Interferon
EP0147819B1 (de) Reinigung von rekombinanten Interleukin-2
DD159782A5 (de) Verfahren zur herstellung eines eine immunologische oder biologische aktivitaet von humanleukozyten-interferon aufweisendes polypeptids
DD202085A5 (de) Verfahren zur herstellung von human-fibroblasten-interferon
DD212748A5 (de) Verfahren zur bildung doppelstraengiger, hybride human-leukozyten-interferone kodierender dns
GB2079291A (en) Interferons and process for their preparation
DD160280A5 (de) Verfahren zur herstellung eines eine immunologische oder biologische aktivitaet von humanfibroblast-interferon aufweisenden polypeptids
DE3308030C2 (de) Tierische Interferone
AU606585B2 (en) Human granulocyte-macrophage colony stimulating factor-like polypeptides and processes for producing them in high yields in microbial cells
CH663032A5 (de) Doppelstraengige dna, replizierbare plasmidische expressionstraeger zur mikrobiellen herstellung von hybrid human-leukozyten-interferon und transformierte mikroorganismen.
AT393690B (de) Homogene, rekombinante immun-interferonfragmente
AT394209B (de) Verfahren zur herstellung neuer mikroorganismen zur produktion von hybriden human-leukozyten-interferonen
AT392082B (de) Das polypeptid interleukin-2 kodierendes gen, rekombinante, dieses gen enthaltende dna, diese rekombinante dna aufweisende zellinien und verfahren zur herstellung von interleukin-2 unter verwendung der genannten zellen
DE3428370A1 (de) Interferon, genetische sequenzen, die hierfuer codieren, und diese produzierende organismen
DE3505060A1 (de) Neue interferone vom typ i, genetische sequenzen, die hierfuer codieren, und diese produzierende organismen
AT394208B (de) Verfahren zur herstelluung von vektoren
AT394207B (de) Verfahren zur herstellung von human-leukozyteninterferonen
DD251789A5 (de) Verfahren zur Herstellung von Rekombinanten Pferde- und Hunde-Interferonen
DD259419A5 (de) Verfahren zur Herstellung von neuen Expressionsplasmiden
DD264706A5 (de) Verfahren zur Herstellung von Polypeptiden (Pferde-Interforon-Gamma)
IL63197A (en) Intraferons for mature human oocytes, their preparation and preparations containing them

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee